000			01711 a2200421 4500
005			20250515012815.0
264		0	_c20060707
008			200607s 0 0 eng d
022			_a0931-0509
024	7		_a10.1093/ndt/gfk050 _2doi
040			_aNLM _beng _cNLM
100	1		_aHjalmarsson, Clara
245	0	0	_aBeneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis. _h[electronic resource]
260			_bNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association _cMay 2006
300			_a1223-30 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnalysis of Variance
650	0	4	_aAnimals
650	0	4	_aBiopsy, Needle
650	0	4	_aDisease Models, Animal
650	0	4	_aFemale
650	0	4	_aGlomerular Filtration Rate _xdrug effects
650	0	4	_aImmunohistochemistry
650	0	4	_aKidney Glomerulus _xdrug effects
650	0	4	_aNephrosis _xdrug therapy
650	0	4	_aOrosomucoid _xpharmacology
650	0	4	_aProbability
650	0	4	_aPuromycin Aminonucleoside
650	0	4	_aRandom Allocation
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReference Values
650	0	4	_aSensitivity and Specificity
700	1		_aLidell, Martin E
700	1		_aHaraldsson, Börje
773	0		_tNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association _gvol. 21 _gno. 5 _gp. 1223-30
856	4	0	_uhttps://doi.org/10.1093/ndt/gfk050 _zAvailable from publisher's website
999			_c16026909 _d16026909